المؤلفون: Iagnocco, AnnaMaria, Lioté, Frédéric, McCarthy, Geraldine, Ramonda, Roberta, Richette, Pascal, Sivera, Francisca, Andrés, Mariano, Cipolletta, Edoardo, Doherty, Michael, Pascual, Eliseo, Perez-Ruiz, Fernando, So, Alexander, Jansen, Tim, Kohler, Minna, Stamp, Lisa, Yinh, Janeth, Adinolfi, Antonella, Arad, Uri, Aung, Thanda, Benillouche, Eva, Bortoluzzi, Alessandra, Dau, Jonathan, Maningding, Ernest, Fang, Meika, Figus, Fabiana, Filippucci, Emilio, Haslett, Janine, Janssen, Matthijs, Kaldas, Marian, Kimoto, Maryann, Leamy, Kelly, Navarro, Geraldine, Sarzi-Puttini, Piercarlo, Scirè, Carlo, Silvagni, Ettore, Sirotti, Silvia, Stack, John, Truong, Linh, Abhishek, Abhishek, Tedeschi, Sara, Pascart, Tristan, Latourte, Augustin, Dalbeth, Nicola, Neogi, Tuhina, Fuller, Amy, Rosenthal, Ann, Becce, Fabio, Bardin, Thomas, Ea, Hang-Korng, Filippou, Georgios, Yokose, Chio, Hendry, Alison, Terkeltaub, Robert, Taylor, William, Choi, Hyon, FitzGerald, John, Xie, Chen

المصدر: Annals of the Rheumatic Diseases. 82(10)

مصطلحات موضوعية: Autoimmune Diseases, Immune Complex Diseases, Immune System Diseases, Humans, United States, Chondrocalcinosis, Rheumatology, Calcium Pyrophosphate, Calcinosis, Syndrome

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/2j09q5c0

المؤلفون: Abhishek, Abhishek, Tedeschi, Sara, Pascart, Tristan, Latourte, Augustin, Dalbeth, Nicola, Neogi, Tuhina, Fuller, Amy, Rosenthal, Ann, Becce, Fabio, Bardin, Thomas, Ea, Hang, Filippou, Georgios, Iagnocco, AnnaMaria, Lioté, Frédéric, McCarthy, Geraldine, Ramonda, Roberta, Richette, Pascal, Sivera, Francisca, Andres, Mariano, Cipolletta, Edoardo, Doherty, Michael, Pascual, Eliseo, Perez-Ruiz, Fernando, So, Alexander, Jansen, Tim, Kohler, Minna, Stamp, Lisa, Yinh, Janeth, Adinolfi, Antonella, Arad, Uri, Aung, Thanda, Benillouche, Eva, Bortoluzzi, Alessandra, Dau, Jonathan, Maningding, Ernest, Fang, Meika, Figus, Fabiana, Filippucci, Emilio, Haslett, Janine, Janssen, Matthijs, Kimoto, Maryann, Leamy, Kelly, Navarro, Geraldine, Sarzi-Puttini, Piercarlo, Scirè, Carlo, Silvagni, Ettore, Sirotti, Silvia, Stack, John, Truong, Linh, Yokose, Chio, Hendry, Alison, Terkeltaub, Robert, Taylor, William, Choi, Hyon, FitzGerald, John, Kaldas, Marian, Xie, Chen

المصدر: Arthritis and Rheumatology. 75(10)

مصطلحات موضوعية: Humans, Calcinosis, Calcium Pyrophosphate, Chondrocalcinosis, Rheumatology, Syndrome, United States

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/2cw5x5xt

المؤلفون: Kaldas, Marian

Thesis Advisors: Lemay, Violaine

مصطلحات موضوعية: corruption, Anti-corruption, Strategy, Egypt, Interdisciplinary, Reforms, Governance, National anti-corruption strategy], Strategie, Égypte, Interdisciplinaire, Réformes, Gouvernance, stratégie nationale de lutte contre la corruption, Social Sciences - Law / Sciences sociales - Droit (UMI : 0398)

الاتاحة: http://hdl.handle.net/1866/24283

المؤلفون: Zell, Monica, Aung, Thanda, Kaldas, Marian, Rosenthal, Ann K, Bai, Bijie, Liu, Tairan, Ozcan, Aydogan, FitzGerald, John D

المصدر: Osteoarthritis and Cartilage Open. 3(1)

مصطلحات موضوعية: CPPD, Calcium pyrophosphate, Crystal arthropathy, Light microscopy

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/6s54p69q

المؤلفون: Hanna, Ramy, Kaldas, Marian, Arman, Farid, Wang, Melissa, Hammer, Terrance, Sinkowitz, Deren, Rastogi, Anjay

مصطلحات موضوعية: acute kidney injury, granuloma, hypercalcemia, hypervitaminosis D, sarcoidosis

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/46j1w6nq
https://escholarship.org/content/qt46j1w6nq/qt46j1w6nq.pdf

المؤلفون: Hanna, Ramy, So, Naomi, Kaldas, Marian, Hou, Jean, Arman, Farid, Sangalang, Michelle, Yanny, Bishoy, Selamet, Umut, Saab, Sammy, Nobakht, Niloofar, Rastogi, Anjay

المصدر: Case Reports in Nephrology and Dialysis. 8(2)

مصطلحات موضوعية: Cryoglobulin antibodies, Hepatitis C virus-associated glomerular disease, Necrotizing crescentic p-ANCA glomerulonephritis, Perinuclear anti-neutrophil cytoplasmic antibodies

وصف الملف: application/pdf

URL الوصول: https://escholarship.org/uc/item/7zw1w5sv
https://escholarship.org/content/qt7zw1w5sv/qt7zw1w5sv.pdf

المؤلفون: Khanna, Dinesh, Khanna, Puja P., Fitzgerald, John D., Singh, Manjit K., Bae, Sangmee, Neogi, Tuhina, Pillinger, Michael H., Merill, Joan, Lee, Susan, Prakash, Shraddha, Kaldas, Marian, Gogia, Maneesh, Perez‐Ruiz, Fernando, Taylor, Will, Lioté, Frédéric, Choi, Hyon, Singh, Jasvinder A., Dalbeth, Nicola, Kaplan, Sanford, Niyyar, Vandana, Jones, Danielle, Yarows, Steven A., Roessler, Blake, Kerr, Gail, King, Charles, Levy, Gerald, Furst, Daniel E., Edwards, N. Lawrence, Mandell, Brian, Schumacher, H. Ralph, Robbins, Mark, Wenger, Neil, Terkeltaub, Robert

المصدر: Arthritis Care & Research ; volume 64, issue 10, page 1447-1461 ; ISSN 2151-464X 2151-4658

الاتاحة: http://dx.doi.org/10.1002/acr.21773
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Facr.21773
http://onlinelibrary.wiley.com/wol1/doi/10.1002/acr.21773/fullpdf

المؤلفون: Kaldas, Marian, Khanna, Puja P., Furst, Daniel E., Clements, Philip J., Kee Wong, Weng, Seibold, James R., Postlethwaite, Arnold E., Khanna, Dinesh, on behalf of the investigators of the human recombinant relaxin and oral bovine collagen clinical trials

مصطلحات موضوعية: CLINICAL

وصف الملف: text/html

Relation: http://rheumatology.oxfordjournals.org/cgi/content/short/48/9/1143; http://dx.doi.org/10.1093/rheumatology/kep202

الاتاحة: http://rheumatology.oxfordjournals.org/cgi/content/short/48/9/1143
https://doi.org/10.1093/rheumatology/kep202

المؤلفون: Hoglen, Niel C., Anselmo, Dean M., Katori, Masamichi, Kaldas, Marian, Shen, Xiu-Da, Valentino, Karen L., Lassman, Charles, Busuttil, Ronald W., Kupiec-Weglinski, Jerzy W., Farmer, Douglas G.

المصدر: Liver Transplantation ; volume 13, issue 3, page 361-366 ; ISSN 1527-6465 1527-6473

الاتاحة: http://dx.doi.org/10.1002/lt.21016
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.21016
https://onlinelibrary.wiley.com/doi/full/10.1002/lt.21016

المؤلفون: Young, Arissa¹ ArissaYoung@mednet.ucla.edu, Kaldas, Marian¹, Khan, Yaqoot¹

المصدر: Journal of Family Practice. Mar2023, Vol. 72 Issue 2, pE9-E11. 3p.

مصطلحات موضوعية: *ANTIPHOSPHOLIPID syndrome, *SYSTEMIC lupus erythematosus

المؤلفون: Khanna, Puja P., Gladue, Heather S., Singh, Manjit K., FitzGerald, John D., Bae, Sangmee, Prakash, Shraddha, Kaldas, Marian, Gogia, Maneesh, Berrocal, Veronica, Townsend, Whitney, Terkeltaub, Robert, Khanna, Dinesh

المصدر: Seminars in Arthritis and Rheumatism ; volume 44, issue 1, page 31-38 ; ISSN 0049-0172

الاتاحة: http://dx.doi.org/10.1016/j.semarthrit.2014.02.003
https://api.elsevier.com/content/article/PII:S0049017214000183?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0049017214000183?httpAccept=text/plain

المؤلفون: Khanna, Dinesh, Fitzgerald, John D., Khanna, Puja P., Bae, Sangmee, Singh, Manjit K., Neogi, Tuhina, Pillinger, Michael H., Merill, Joan, Lee, Susan, Prakash, Shraddha, Kaldas, Marian, Gogia, Maneesh, Perez‐ruiz, Fernando, Taylor, Will, Lioté, Frédéric, Choi, Hyon, Singh, Jasvinder A., Dalbeth, Nicola, Kaplan, Sanford, Niyyar, Vandana, Jones, Danielle, Yarows, Steven A., Roessler, Blake, Kerr, Gail, King, Charles, Levy, Gerald, Furst, Daniel E., Edwards, N. Lawrence, Mandell, Brian, Schumacher, H. Ralph, Robbins, Mark, Wenger, Neil, Terkeltaub, Robert

المساهمون: University of Michigan, Ann Arbor, IHA University of Michigan Health System, Chelsea, University of California, Los Angeles, Université Paris Diderot, Sorbonne Paris Cité, and Hôpital Lariboisière, Paris, France, VA Medical Center and University of Alabama, Birmingham, VA Healthcare System and University of California, San Diego, University of Auckland, Auckland, New Zealand, Oklahoma Medical Research Foundation, Oklahoma City, VA Medical Center and New York University School of Medicine, New York, Boston University Medical Center, Boston, Massachusetts, Rochester General Health System, Rochester, New York, University of Otago, Wellington, New Zealand, VA Healthcare System/University of California, San Diego, 111K, 3350 La Jolla Village Drive, San Diego, CA 92161, Harvard Vanguard Medical Associates/Atrius Health, Somerville, Massachusetts, VA Medical Center and University of Pennsylvania, Philadelphia, Hospital Universitario Cruces, Vizcaya, Spain, Cleveland Clinic, Cleveland, Ohio, University of Florida, Gainesville, Southern California Permanente Medical Group, Downey, North Mississippi Medical Center, Tupelo, Veterans Affairs Medical Center, Washington, DC, Emory University, Atlanta, Georgia, Oral and Maxillofacial Surgery, Beverly Hills, California

مصطلحات موضوعية: Geriatrics, Health Sciences

وصف الملف: application/pdf

Relation: Khanna, Dinesh; Fitzgerald, John D.; Khanna, Puja P.; Bae, Sangmee; Singh, Manjit K.; Neogi, Tuhina; Pillinger, Michael H.; Merill, Joan; Lee, Susan; Prakash, Shraddha; Kaldas, Marian; Gogia, Maneesh; Perez‐ruiz, Fernando; Taylor, Will; Lioté, Frédéric; Choi, Hyon; Singh, Jasvinder A.; Dalbeth, Nicola; Kaplan, Sanford; Niyyar, Vandana; Jones, Danielle; Yarows, Steven A.; Roessler, Blake; Kerr, Gail; King, Charles; Levy, Gerald; Furst, Daniel E.; Edwards, N. Lawrence; Mandell, Brian; Schumacher, H. Ralph; Robbins, Mark; Wenger, Neil; Terkeltaub, Robert (2012). "2012 American College of Rheumatology guidelines for management of gout. Part 1: Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia." Arthritis Care & Research 64(10): 1431-1446.; https://hdl.handle.net/2027.42/93740; Arthritis Care & Research; Singh JA, Reddy SG, Kundukulam J. Risk factors for gout and prevention: a systematic review of the literature. Curr Opin Rheumatol 2011; 23: 192 – 202.; Desai MA, Peterson JJ, Garner HW, Kransdorf MJ. Clinical utility of dual‐energy CT for evaluation of tophaceous gout. Radiographics 2011; 31: 1365 – 75.; Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011; 63: 3136 – 41.; Bhole V, de Vera M, Rahman MM, Krishnan E, Choi H. Epidemiology of gout in women: fifty‐two–year followup of a prospective cohort. Arthritis Rheum 2010; 62: 1069 – 76.; Pillinger MH, Goldfarb DS, Keenan RT. Gout and its comorbidities. Bull NYU Hosp Jt Dis 2010; 68: 199 – 203.; Brook RA, Forsythe A, Smeeding JE, Lawrence EN. Chronic gout: epidemiology, disease progression, treatment and disease burden. Curr Med Res Opin 2010; 26: 2813 – 21.; Roddy E, Doherty M. Epidemiology of gout. Arthritis Res Ther 2010; 12: 223.; McAdams DeMarco MA, Maynard JW, Baer AN, Gelber AC, Young JH, Alonso A, et al. Diuretic use, increased serum urate levels, and risk of incident gout in a population‐based study of adults with hypertension: the Atherosclerosis Risk in Communities cohort study. Arthritis Rheum 2012; 64: 121 – 9.; Choi HK. A prescription for lifestyle change in patients with hyperuricemia and gout. Curr Opin Rheumatol 2010; 22: 165 – 72.; Becker MA, Schumacher HR, Benjamin KL, Gorevic P, Greenwald M, Fessel J, et al. Quality of life and disability in patients with treatment‐failure gout. J Rheumatol 2009; 36: 1041 – 8.; Khanna PP, Khanna D. Health‐related quality of life and outcome measures in gout. In: Terkeltaub R, editor. Gout and other crystal arthropathies. 1st ed. Philadelphia: Elsevier; 2011. p. 217 – 25.; Singh JA, Hodges JS, Toscano JP, Asch SM. Quality of care for gout in the US needs improvement. Arthritis Rheum 2007; 57: 822 – 9.; Harrold LR, Andrade SE, Briesacher BA, Raebel MA, Fouayzi H, Yood RA, et al. Adherence with urate‐lowering therapies for the treatment of gout. Arthritis Res Ther 2009; 11: R46.; Khanna D, Khanna PP, FitzGerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1447 – 61.; Neogi T, George J, Rekhraj S, Struthers AD, Choi H, Terkeltaub RA. Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal [review]. Arthritis Rheum 2012; 64: 327 – 38.; Brook R. The RAND/UCLA Appropriateness Method. In: McCormick KA, Moore SR, Siegel RA, editors. Methodology perspectives: AHCPR no. 95‐0009. Rockville (MD): Public Health Service; 1994. p. 59 – 70.; Zhang W, Doherty M, Pascual E, Bardin T, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part I: diagnosis. Report of a task force of the Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1301 – 11.; Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312 – 24.; Romeijnders AC, Gorter KJ. Summary of the Dutch College of General Practitioners' “gout” standard. Ned Tijdschr Geneeskd 2002; 146: 309 – 13. In Dutch.; Yamanaka H. Revised version of guideline for the management of hyperuricemia and gout. Nihon Rinsho 2008; 66: 643 – 6. In Japanese.; Jordan KM, Cameron JS, Snaith M, Zhang W, Doherty M, Seckl J, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guideline for the management of gout. Rheumatology (Oxford) 2007; 46: 1372 – 4.; Stevenson M, Pandor A. Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal. Pharmacoeconomics 2011; 29: 133 – 40.; Becker MA, Schumacher HR, Espinoza LR, Wells AF, MacDonald P, Lloyd E, et al. The urate‐lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Res Ther 2010; 12: R63.; Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez‐Urena SR, Treadwell EL, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 2011; 306: 711 – 20.; Choi HK, Al‐Arfaj AM, Eftekhari A, Munk PL, Shojania K, Reid G, et al. Dual energy computed tomography in tophaceous gout. Ann Rheum Dis 2009; 68: 1609 – 12.; Dalbeth N, Schauer C, MacDonald P, Perez‐Ruiz F, Schumacher HR, Hamburger S, et al. Methods of tophus assessment in clinical trials of chronic gout: a systematic literature review and pictorial reference guide. Ann Rheum Dis 2011; 70: 597 – 604.; Shekelle PG, Woolf SH, Eccles M, Grimshaw J. Clinical guidelines: developing guidelines. BMJ 1999; 318: 593 – 6.; Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation 2005; 112: e154 – 235.; Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 625 – 39.; Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis. Arthritis Care Res (Hoboken) 2010; 62: 1515 – 26.; Rees F, Jenkins W, Doherty M. Patients with gout adhere to curative treatment if informed appropriately: proof‐of‐ concept observational study. Ann Rheum Dis 2012. E‐pub ahead of print.; Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006; 54: 2688 – 96.; Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. Long‐term cardiovascular mortality among middle‐aged men with gout. Arch Intern Med 2008; 168: 1104 – 10.; Dalbeth N, Ames R, Gamble GD, Horne A, Wong S, Kuhn‐Sherlock B, et al. Effects of skim milk powder enriched with glycomacropeptide and G600 milk fat extract on frequency of gout flares: a proof‐of‐concept randomised controlled trial. Ann Rheum Dis 2012; 71: 929 – 34.; Dessein PH, Shipton EA, Stanwix AE, Joffe BI, Ramokgadi J. Beneficial effects of weight loss associated with moderate calorie/carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000; 59: 539 – 43.; Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine‐rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093 – 103.; Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004; 363: 1277 – 81.; Choi HK, Willett W, Curhan G. Fructose‐rich beverages and the risk of gout in women. JAMA 2010; 304: 2270 – 8.; Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 36: 309 – 12.; Zhang Y, Chen C, Choi H, Chaisson C, Hunter D, Niu J, et al. Purine‐rich foods intake and recurrent gout attacks. Ann Rheum Dis 2012. E‐pub ahead of print.; Tsai YT, Liu JP, Tu YK, Lee MS, Chen PR, Hsu HC, et al. Relationship between dietary patterns and serum uric acid concentrations among ethnic Chinese adults in Taiwan. Asia Pac J Clin Nutr 2012; 21: 263 – 70.; Zhang Y, Woods R, Chaisson CE, Neogi T, Niu J, McAlindon TE, et al. Alcohol consumption as a trigger of recurrent gout attacks. Am J Med 2006; 119: 800.e13 – 8.; Stamp LK, Taylor WJ, Jones PB, Dockerty JL, Drake J, Frampton C, et al. Starting dose is a risk factor for allopurinol hypersensitivity syndrome: a proposed safe starting dose of allopurinol. Arthritis Rheum 2012; 64: 2529 – 36.; Reinders MK, van Roon EN, Jansen TL, Delsing J, Griep EN, Hoekstra M, et al. Efficacy and tolerability of urate‐lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol. Ann Rheum Dis 2009; 68: 51 – 6.; Reinders MK, Haagsma C, Jansen TL, van Roon EN, Delsing J, van de Laar MA, et al. A randomised controlled trial on the efficacy and tolerability with dose escalation of allopurinol 300–600 mg/day versus benzbromarone 100–200 mg/day in patients with gout. Ann Rheum Dis 2009; 68: 892 – 7.; Stamp LK, O'Donnell JL, Zhang M, James J, Frampton C, Barclay ML, et al. Using allopurinol above the dose based on creatinine clearance is effective and safe in patients with chronic gout, including those with renal impairment. Arthritis Rheum 2011; 63: 412 – 21.; Lupton G, Odom R. Severe allopurinol hypersensitivity syndrome. J Am Acad Dermatol 1979; 72: 1361 – 8.; Arellano F, Sacristan J. Allopurinol hypersensitivity syndrome: a review. Ann Pharmacother 1993; 27: 337 – 43.; Zineh I, Mummaneni P, Lyndly J, Amur S, La Grenade LA, Chang SH, et al. Allopurinol pharmacogenetics: assessment of potential clinical usefulness. Pharmacogenomics 2011; 12: 1741 – 9.; Hande KR. Evaluation of a thiazide‐allopurinol drug interaction. Am J Med Sci 1986; 292: 213 – 6.; Chao J, Terkeltaub R. A critical reappraisal of allopurinol dosing, safety, and efficacy for hyperuricemia in gout. Curr Rheumatol Rep 2009; 11: 135 – 40.; Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity: description and guidelines for prevention in patients with renal insufficiency. Am J Med 1984; 76: 47 – 56.; Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N. Association of HLA‐B*5801 allele and allopurinol‐induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta‐analysis. BMC Med Genet 2011; 12: 118.; Lee MH, Stocker SL, Anderson J, Phillips EJ, Nolan D, Williams KM, et al. Initiating allopurinol therapy: do we need to know the patient's HLA status? Intern Med J 2011; 42: 411 – 6.; Jung JW, Song WJ, Kim YS, Joo KW, Lee KW, Kim SH, et al. HLA‐B58 can help the clinical decision on starting allopurinol in patients with chronic renal insufficiency. Nephrol Dial Transplant 2011; 26: 3567 – 72.; Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, et al. HLA‐B*5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol. Proc Natl Acad Sci USA 2005; 102: 4134 – 9.; Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, et al. Strong association between HLA‐B*5801 and allopurinol‐induced Stevens‐Johnson syndrome and toxic epidermal necrolysis in a Thai population. Pharmacogenet Genomics 2009; 19: 704 – 9.; Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, et al, for the RegiSCAR Study Group. A European study of HLA‐B in Stevens‐Johnson syndrome and toxic epidermal necrolysis related to five high‐risk drugs. Pharmacogenet Genomics 2008; 18: 99 – 107.; Perez‐Ruiz F, Hernandez‐Baldizon S, Herrero‐Beites AM, Gonzalez‐Gay MA. Risk factors associated with renal lithiasis during uricosuric treatment of hyperuricemia in patients with gout. Arthritis Care Res (Hoboken) 2010; 62: 1299 – 305.; Thompson GR, Duff IF, Robinson WD, Mikkelsen WM, Galindez H. Long term uricosuric therapy in gout. Arthritis Rheum 1962; 5: 384 – 96.; Pineda C, Amezcua‐Guerra LM, Solano C, Rodriguez‐Henriquez P, Hernandez‐Diaz C, Vargas A, et al. Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study. Arthritis Res Ther 2011; 13: R4.; Ottaviani S, Allard A, Bardin T, Richette P. An exploratory ultrasound study of early gout. Clin Exp Rheumatol 2011; 29: 816 – 21.; Perez‐Ruiz F, Calabozo M, Pijoan JI, Herrero‐Beites AM, Ruibal A. Effect of urate‐lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002; 47: 356 – 60.; Takahashi S, Moriwaki Y, Yamamoto T, Tsutsumi Z, Ka T, Fukuchi M. Effects of combination treatment using anti‐hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism. Ann Rheum Dis 2003; 62: 572 – 5.; Reinders MK, van Roon EN, Houtman PM, Brouwers JR, Jansen TL. Biochemical effectiveness of allopurinol and allopurinol‐probenecid in previously benzbromarone‐treated gout patients. Clin Rheumatol 2007; 26: 1459 – 65.; Thiele RG, Schlesinger N. Ultrasonography shows disappearance of monosodium urate crystal deposition on hyaline cartilage after sustained normouricemia is achieved. Rheumatol Int 2010; 30: 495 – 503.; Perez‐Ruiz F, Hernando I, Villar I, Nolla JM. Correction of allopurinol dosing should be based on clearance of creatinine, but not plasma creatinine levels: another insight to allopurinol‐related toxicity. J Clin Rheumatol 2005; 11: 129 – 33.; Becker MA, Schumacher HR Jr, Wortmann RL, MacDonald PA, Eustace D, Palo WA, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450 – 61.; Schumacher HR Jr, Becker MA, Wortmann RL, MacDonald PA, Hunt B, Streit J, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28‐week, phase III, randomized, double‐blind, parallel‐group trial. Arthritis Rheum 2008; 59: 1540 – 8.; Neogi T. Clinical practice: gout. N Engl J Med 2011; 364: 443 – 52.; Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 2010; 6: 30 – 8.; Dalbeth N, Aati O, Gao A, House M, Liu Q, Horne A, et al. Assessment of tophus size: a comparison between physical measurement methods and dual‐energy computed tomography scanning. J Clin Rheumatol 2012; 18: 23 – 7.; Dalbeth N, Clark B, Gregory K, Gamble G, Sheehan T, Doyle A, et al. Mechanisms of bone erosion in gout: a quantitative analysis using plain radiography and computed tomography. Ann Rheum Dis 2009; 68: 1290 – 5.

الاتاحة: https://hdl.handle.net/2027.42/93740
https://doi.org/10.1002/acr.21772

المؤلفون: Khanna, Dinesh, FitzGerald, John D., Khanna, Puja P., Bae, Sangmee, Singh, Manjit, Neogi, Tuhina, Pillinger, Michael H., Merill, Joan, Lee, Susan, Prakash, Shraddha, Kaldas, Marian, Gogia, Maneesh, Perez-Ruiz, Fernando, Taylor, Will, Lioté, Frédéric, Choi, Hyon, Singh, Jasvinder A., Dalbeth, Nicola, Kaplan, Sanford, Niyyar, Vandana, Jones, Danielle, Yarows, Steven A., Roessler, Blake, Kerr, Gail, King, Charles, Levy, Gerald, Furst, Daniel E., Edwards, N. Lawrence, Mandell, Brian, Schumacher, H. Ralph, Robbins, Mark, Wenger, Neil, Terkeltaub, Robert

مصطلحات موضوعية: Article

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::8df8b584b5cfb1d33fe9d5cfbe42842d
https://europepmc.org/articles/PMC3683400/

المؤلفون: Farmer, Douglas G., Kaldas, Fady, Anselmo, Dean, Katori, Masamichi, Shen, Xiu-Da, Lassman, Charles, Kaldas, Marian, Clozel, Martine, Busuttil, Ronald W., Kupiec-Weglinski, Jerzy

المساهمون: Dumont Research Fund, JoAnn Barr Foundation

المصدر: Liver Transplantation ; volume 14, issue 12, page 1737-1744 ; ISSN 1527-6465

الاتاحة: http://dx.doi.org/10.1002/lt.21621
https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Flt.21621
http://onlinelibrary.wiley.com/wol1/doi/10.1002/lt.21621/fullpdf

المؤلفون: Farmer, Douglas G., Kaldas, Fady, Anselmo, Dean, Katori, Masamichi, Shen, Xiu-Da, Lassman, Charles, Kaldas, Marian, Clozel, Martine, Busuttil, Ronald W., Kupiec-Weglinski, Jerzy

مصطلحات موضوعية: Endothelin Receptor Antagonists, Male, Pyridines, Hemodynamics, Tetrazoles, Article, Liver Transplantation, Rats, Rats, Sprague-Dawley, Disease Models, Animal, Liver, Ischemia, Reperfusion Injury, Animals, Warm Ischemia

URL الوصول: https://explore.openaire.eu/search/publication?articleId=pmid________::aed1fc13af5d3f8eabd75c3581373b2d
https://europepmc.org/articles/PMC2975480/

المؤلفون: Kaldas, Marian

المساهمون: Lemay, Violaine

مصطلحات موضوعية: corruption, Anti-corruption, Strategy, Egypt, Interdisciplinary, Reforms, Governance, National anti-corruption strategy], Strategie, Égypte, Interdisciplinaire, Réformes, Gouvernance, stratégie nationale de lutte contre la corruption, Social Sciences - Law / Sciences sociales - Droit (UMI : 0398)

وصف الملف: application/pdf

Relation: http://hdl.handle.net/1866/24283

الاتاحة: http://hdl.handle.net/1866/24283

المؤلفون: Abhishek Abhishek, Sara K Tedeschi, Tristan Pascart, Augustin Latourte, Nicola Dalbeth, Tuhina Neogi, Amy Fuller, Ann Rosenthal, Fabio Becce, Thomas Bardin, Hang-Korng Ea, Georgios Filippou, John Fitzgerald, AnnaMaria Iagnocco, Frédéric Lioté, Geraldine M McCarthy, Roberta Ramonda, Pascal Richette, Francisca Sivera, Mariano Andrés, Edoardo Cipolletta, Michael Doherty, Eliseo Pascual, Fernando Perez-Ruiz, Alexander So, Tim L Jansen, Minna J Kohler, Lisa K Stamp, Janeth Yinh, Antonella Adinolfi, Uri Arad, Thanda Aung, Eva Benillouche, Alessandra Bortoluzzi, Jonathan Dau, Ernest Maningding, Meika A Fang, Fabiana A Figus, Emilio Filippucci, Janine Haslett, Matthijs Janssen, Marian Kaldas, Maryann Kimoto, Kelly Leamy, Geraldine M Navarro, Piercarlo Sarzi-Puttini, Carlo Scirè, Ettore Silvagni, Silvia Sirotti, John R Stack, Linh Truong, Chen Xie, Chio Yokose, Alison M Hendry, Robert Terkeltaub, William J Taylor, Hyon K Choi

المساهمون: Abhishek, Abhishek, K Tedeschi, Sara, Pascart, Tristan, Latourte, Augustin, Dalbeth, Nicola, Neogi, Tuhina, Fuller, Amy, Rosenthal, Ann, Becce, Fabio, Bardin, Thoma, Ea, Hang-Korng, Filippou, Georgio, Fitzgerald, John, Iagnocco, Annamaria, Lioté, Frédéric, M McCarthy, Geraldine, Ramonda, Roberta, Richette, Pascal, Sivera, Francisca, Andrés, Mariano, Cipolletta, Edoardo, Doherty, Michael, Pascual, Eliseo, Perez-Ruiz, Fernando, So, Alexander, L Jansen, Tim, J Kohler, Minna, K Stamp, Lisa, Yinh, Janeth, Adinolfi, Antonella, Arad, Uri, Aung, Thanda, Benillouche, Eva, Bortoluzzi, Alessandra, Dau, Jonathan, Maningding, Ernest, A Fang, Meika, A Figus, Fabiana, Filippucci, Emilio, Haslett, Janine, Janssen, Matthij, Kaldas, Marian, Kimoto, Maryann, Leamy, Kelly, M Navarro, Geraldine, Sarzi-Puttini, Piercarlo, Scirè, Carlo, Silvagni, Ettore, Sirotti, Silvia, R Stack, John, Truong, Linh, Xie, Chen, Yokose, Chio, M Hendry, Alison, Terkeltaub, Robert, J Taylor, William, K Choi, Hyon

مصطلحات موضوعية: Autoimmune Disease, Immune Complex Disease, Immune System Diseases

وصف الملف: STAMPA

Relation: info:eu-repo/semantics/altIdentifier/pmid/37495237; info:eu-repo/semantics/altIdentifier/wos/WOS:001037656200001; volume:82; issue:10; firstpage:1248; lastpage:1257; numberofpages:10; journal:ANNALS OF THE RHEUMATIC DISEASES; https://hdl.handle.net/11392/2520371; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85166439712; https://ard.bmj.com/content/82/10/1248; https://nottingham-repository.worktribe.com/preview/23479440/CPPD_classification_criteria_manuscript-2023-May-17_clean_submittedtoUoNrepository.pdf

الاتاحة: https://hdl.handle.net/11392/2520371
https://doi.org/10.1136/ard-2023-224575
https://ard.bmj.com/content/82/10/1248
https://nottingham-repository.worktribe.com/preview/23479440/CPPD_classification_criteria_manuscript-2023-May-17_clean_submittedtoUoNrepository.pdf